DUPILUMAB VERSUS OMALIZUMAB IN TYPE-2-HIGH PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPS AND COEXISTENT ASTHMA

Annals of Allergy, Asthma & Immunology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles